Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Island Pharmaceuticals Ltd ( (AU:ILA) ).
Island Pharmaceuticals Limited has issued 11,142,061 fully paid ordinary shares following the exercise of unlisted options at an issue price of $0.07 per share. This issuance was conducted without disclosure to investors under Part 6D.2 of the Corporations Act, and the company confirms compliance with relevant provisions of the Act. The announcement reflects the company’s ongoing operational activities and adherence to regulatory standards.
More about Island Pharmaceuticals Ltd
Island Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the development and commercialization of pharmaceutical products. The company is listed on the Australian Securities Exchange under the ticker ASX: ILA.
Average Trading Volume: 590,898
Technical Sentiment Signal: Buy
Current Market Cap: A$37.77M
For an in-depth examination of ILA stock, go to TipRanks’ Overview page.